Today, White House Office of National Drug Control Policy (ONDCP) Director Jim Carroll announced the start of a public comment period to assist ONDCP in its development of criteria for designating emerging drug threats. The advance notice comment period will be open from May 15, 2020, through June 30, 2020.“It is vital that we evaluate emerging drug trends and receive input from policy experts and people on the ground experiencing the firsthand impacts of the drug crisis, particularly as we face new challenges associated with the COVID-19 pandemic. The Trump Administration is actively monitoring drug threats in order to successfully...